IGC Pharma, Inc. (IGC)
0.2908
-0.01
(-2.38%)
USD |
NYAM |
Dec 08, 16:00
0.2894
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Shareholders Equity (Quarterly): 8.092M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Esperion Therapeutics, Inc. | -451.36M |
| Theravance Biopharma, Inc. | 232.68M |
| NRX Pharmaceuticals, Inc. | -25.76M |
| CEL-SCI Corp. | 7.025M |
| AIM ImmunoTech, Inc. | -6.077M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.743M |
| Total Liabilities (Quarterly) | 1.651M |
| Debt to Equity Ratio | 0.0185 |
| Current Ratio | 1.324 |
| Net Debt Paydown Yield | 0.10% |